BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 17, 2005
View Archived Issues
P-selectin inhibitor from Wyeth effective in models of vascular inflammation and atherosclerosis
Read More
Similar PK parameters reported for two oral formulations of rizatriptan in healthy subjects
Read More
Central effects of cannabinoids
Read More
NK1 receptor antagonism elicits antitumor activity
Read More
New data on the pharmacokinetics and pharmacodynamics of dabigatran
Read More
Update on the effects and safety of INS-50589
Read More
Phase II data on rhThrombin in the management of postoperative bleeding
Read More
Active second quarter at Schering-Plough
Read More
Meda to acquire Viatris
Read More
RegeneRx collaborates with Children's National Medical Center for TB4
Read More
Samaritan establishes Samaritan Europe
Read More
Teva receives follow-up approvable letter for Agilect
Read More
Acambis and VIB team up on flu vaccine development
Read More
ODAC schedules reviews for September meeting
Read More
European MRP completed for Remodulin
Read More
ChondroGene forms alliance with UCSF
Read More
FDA explains clinical hold of phase II study of arimoclomol for ALS
Read More
Orthokine shows efficacy for osteoarthritis
Read More
ChemGenex receives grants for diabetes research
Read More
Corautus Genetics signs agreements for VEGF-2 for diabetic neuropathy
Read More
AnGes and Avontec sign crosslicense agreement
Read More
Positive outcomes from phase III study of regadenoson for MPI
Read More
FDA approval for Fortical
Read More
New therapeutics for cancer disclosed in recent patent literature
Read More
Recent patents reveal novel agents for respiratory diseases
Read More
Therapeutic agents for arthritis and other musculoskeletal diseases prepared and tested
Read More